Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial – The Lancet
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial The Lancet
People with severe mental illnesses such as schizophrenia are three times more likely to smoke than the wider population, contributing to widening health …
Posted on Monday, April 8th, 2019 at 3:42 pm. Filed under: News Feeds RSS 2.0 feed.
Leave a Reply
You must be logged in to post a comment.